Predictors for de novo stress urinary incontinence following pelvic reconstruction surgery with transvaginal single-incisional mesh

Pei-Chi Wu, Chin-Hu Wu, Kun-Ling Lin, Yiyin Liu, Zixi Loo, Yung-Chin Lee, Cheng-Yu Long, Pei-Chi Wu, Chin-Hu Wu, Kun-Ling Lin, Yiyin Liu, Zixi Loo, Yung-Chin Lee, Cheng-Yu Long

Abstract

The study aims to identify predictors for de novo stress urinary incontinence (SUI) following Elevate mesh surgery. A total of 164 women who underwent Elevate mesh surgeries between November 2011 and February 2014 in a single center were included. Seventy-three women were excluded due to preoperative incontinence or concomitant mid-urethral sling surgery. Fourteen others were excluded due to incomplete medical records. Fisher's exact test and χ2 test were applied. The univariate logistic regression was used for odds ratios. Of the 77 continent women, 24 (31.2%) experienced de novo SUI after the operation. Significantly more women with de novo SUI were over the age of 64 years (75.0% vs. 47.2%, p = 0.023, OR 3.36, 95% CI 1.15-9.79). Preoperative occult urodynamic stress incontinence (29.2% vs. 3.8%, p = 0.003, OR 10.0, 95% CI 2.0-50.0) and previous SUI history (41.7% vs. 7.6%, p = 0.001, OR 9.1, 95% CI 2.38-33.3) were 2 other predictors of de novo SUI postoperatively. In conclusion, age over 64 years old, occult urodynamic stress incontinence, and previous history of SUI are 3 significant predictors for de novo SUI following the single-incision mesh surgeries.

Conflict of interest statement

The authors declare no competing interests.

References

    1. Smith FJ, Holman CD, Moorin RE, Tsokos N. Lifetime risk of undergoing surgery for pelvic organ prolapse. Obstet Gynecol. 2010;116:1096–100. doi: 10.1097/AOG.0b013e3181f73729.
    1. Lensen EJ, Withagen MI, Kluivers KB, Milani AL, Vierhout ME. Urinary incontinence after surgery for pelvic organ prolapse. Neurourol Urodyn. 2013;32:455–9. doi: 10.1002/nau.22327.
    1. Brubaker L, et al. Abdominal sacrocolpopexy with Burch colposuspension to reduce urinary stress incontinence. N Engl J Med. 2006;354:1557–66. doi: 10.1056/NEJMoa054208.
    1. Wei JT, et al. A midurethral sling to reduce incontinence after vaginal prolapse repair. N Engl J Med. 2012;366:2358–67. doi: 10.1056/NEJMoa1111967.
    1. van der Ploeg JM, van der Steen A, Zwolsman S, van der Vaart CH, Roovers J. Prolapse surgery with or without incontinence procedure: a systematic review and meta-analysis. BJOG. 2018;125:289–97. doi: 10.1111/1471-0528.14943.
    1. Baessler K, et al. Surgery for women with pelvic organ prolapse with or without stress urinary incontinence. Cochrane Database Syst Rev. 2018;8:Cd013108.
    1. Cortesse A, Cardot V, Basset V, Le Normand L, Donon L. Treatment of Urinary incontinence associated with genital prolapse: Clinical practice guidelines. Prog Urol. 2016;26(Suppl 1):S89–97. doi: 10.1016/S1166-7087(16)30431-6.
    1. Drain A, et al. Use of Concomitant Stress Incontinence Surgery at Time of Pelvic Organ Prolapse Surgery Since Release of the 2011 Notification on Serious Complications Associated with Transvaginal Mesh. J Urol. 2017;197:1092–8. doi: 10.1016/j.juro.2016.11.087.
    1. Chermansky CJ, Krlin RM, Winters JC. Selective management of the urethra at time of pelvic organ prolapse repair: an assessment of postoperative incontinence and patient satisfaction. J Urol. 2012;187:2144–8. doi: 10.1016/j.juro.2012.01.065.
    1. Long CY, et al. Urodynamic comparison of continent and incontinent women with severe uterovaginal prolapse. J Reprod Med. 2004;49:33–7.
    1. Kuribayashi M, et al. Predictor of de novo stress urinary incontinence following TVM procedure: a further analysis of preoperative voiding function. Int Urogynecol J. 2013;24:407–11. doi: 10.1007/s00192-012-1882-0.
    1. Lo TS, Bt Karim N, Nawawi EA, Wu PY, Nusee Z. Predictors for de novo stress urinary incontinence following extensive pelvic reconstructive surgery. Int Urogynecol J. 2015;26:1313–9. doi: 10.1007/s00192-015-2685-x.
    1. Maher C, et al. Surgery for women with anterior compartment prolapse. Cochrane Database Syst Rev. 2016;11:Cd004014.
    1. Ker CR, Lin KL, Loo ZX, Juan YS, Long CY. Comparison of Uphold(TM) Vaginal Mesh Procedure with Hysterectomy or Uterine Preservation for the Treatment of Pelvic Organ Prolapse. Sci Rep. 2018;8:9438. doi: 10.1038/s41598-018-27765-8.
    1. Visco AG, et al. The role of preoperative urodynamic testing in stress-continent women undergoing sacrocolpopexy: the Colpopexy and Urinary Reduction Efforts (CARE) randomized surgical trial. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:607–14. doi: 10.1007/s00192-007-0498-2.
    1. Chang TC, Hsiao SM, Chen CH, Wu WY, Lin HH. Utilizing preoperative 20-minute pad testing with vaginal gauze packing for indicating concomitant midurethral sling during cystocele repair. Eur J Obstet Gynecol Reprod Biol. 2014;172:127–30. doi: 10.1016/j.ejogrb.2013.10.008.
    1. Lo TS, et al. Comparison between Elevate anterior/apical system and Perigee system in pelvic organ prolapse surgery: clinical and sonographic outcomes. Int Urogynecol J. 2015;26:391–400. doi: 10.1007/s00192-014-2492-9.
    1. Liang CC, Chang YL, Chang SD, Lo TS, Soong YK. Pessary test to predict postoperative urinary incontinence in women undergoing hysterectomy for prolapse. Obstet Gynecol. 2004;104:795–800. doi: 10.1097/01.AOG.0000140689.90131.01.
    1. de Tayrac R, Gervaise A, Chauveaud-Lambling A, Fernandez H. Combined genital prolapse repair reinforced with a polypropylene mesh and tension-free vaginal tape in women with genital prolapse and stress urinary incontinence: a retrospective case-control study with short-term follow-up. Acta Obstet Gynecol Scand. 2004;83:950–4. doi: 10.1111/j.0001-6349.2004.00499.x.
    1. Khayyami Y, Lose G, Klarskov N. Prolapse reduction deteriorates the urethral closure mechanism. Int Urogynecol J. 2019;30:489–93. doi: 10.1007/s00192-018-3647-x.
    1. Lo TS. One-year outcome of concurrent anterior and posterior transvaginal mesh surgery for treatment of advanced urogenital prolapse: case series. J Minim Invasive Gynecol. 2010;17:473–9. doi: 10.1016/j.jmig.2010.03.003.
    1. U.S. Food and Drug Administration. Urogynecologic surgical mesh implants. Available at, (2019).
    1. Long. C. Y. et al. Comparison of clinical outcomes using “elevate anterior” versus “Perigee” system devices for the treatment of pelvic organ prolapse. Biomed Res Int. 479610 (2015).
    1. Haylen BT, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010;21:5–26. doi: 10.1007/s00192-009-0976-9.
    1. Homma Y, et al. Symptom assessment tool for overactive bladder syndrome–overactive bladder symptom score. Urology. 2006;68:318–23. doi: 10.1016/j.urology.2006.02.042.
    1. Abrams P, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21:167–78. doi: 10.1002/nau.10052.
    1. Abrams P, Blaivas JG, Stanton SL, Andersen JT. The standardisation of terminology of lower urinary tract function. The International Continence Society Committee on Standardisation of Terminology. Scand J Urol Nephrol Suppl. 1988;114:5–19.
    1. Groutz A, Blaivas JG, Chaikin DC. Bladder outlet obstruction in women: definition and characteristics. Neurourol Urodyn. 2001;19:213–20. doi: 10.1002/(SICI)1520-6777(2000)19:3<213::AID-NAU2>;2-U.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj